US DMF Abiraterone Acetate API and CYP17 Inhibitor Oncology Ingredient from Original Manufacturer

Original Manufacturer: Shandong Anhong Pharmaceutical Co., Ltd.
Chinese CDE Registration: Y20180000623 — API 
US DMF: Active — Available for Abiraterone
CEP: Please contact us for details
EU GMP Status: Company holds EU GMP certification 
FDA Inspection Status: OAI (June 2026)
Standard: Please contact us for details
Disclaimer: All detailed product information shall be subject to the issued final COA. US DMF Letters of Authorization (LOA) are available to qualified buyers upon request. Product-specific CEP status for Abiraterone Acetate must be confirmed with our team before relying on any EU filing pathway. The manufacturing site's FDA inspection status (OAI, June 2026) is disclosed for buyer awareness. Buyers are responsible for verifying regulatory eligibility for their target market.